DIGITAL HEALTH
Creating an equitable distribution of oxygen Camcon ’ s aim with the BiMOD is to :
• Avoid the use of invasive mechanical ventilation in respiratory failure patients
• Reduce the amount of oxygen used
• Reduce the work of clinical staff in intensive care to allow more time with a great number of patients
“ We have seen some hospitals run out of oxygen in less developed countries , as well as in developed ones ”
PROF . TIM HIGENBOTTAM CHIEF MEDICAL OFFICER , CAMCON
As soon as Camcon Medical has cleared the necessary clinical trials and approvals , it plans to work with major manufacturing and distribution corporations , in order to make its technology available internationally . Through saving oxygen alone , this will add largely to a fairer distribution . A large reduction in oxygen use will also have financial and environmental benefits for hospitals .
The design and development of the BiMOD is a continuous evolution that encompasses the latest understanding of the practice of supporting patients with respiratory failure . “ Our present goal is to introduce the first clinical devices into phase one clinical studies , to demonstrate safety and delivery of enhanced gas exchange ,” said Professor Tim Higenbottam . “ In the most common causes of respiratory failure , gas exchange in the lungs is reduced as the air that is inhaled does not travel to areas of the lungs , which are well perfused with blood . BiMOD has been designed to target those working areas of the lungs with oxygen based on a patient ’ s own breathing pattern .”
To get the BiMOD to market as quickly as possible , Camcon needs corporate partners who want to support the respiratory health revolution , reduce the carbon footprint of medical oxygen and ensure a more equitable distribution around the world . From looking at the healthcare landscape today , that should not take too long . healthcareglobal . com 63